Viewing Study NCT01105650


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2026-07-01 @ 6:29 PM
Study NCT ID: NCT01105650
Status: COMPLETED
Last Update Posted: 2017-12-28
First Post: 2010-04-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Fallopian Tube Cancer View
None Primary Peritoneal Cancer View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent ovarian cancer View
None recurrent fallopian tube cancer View
None recurrent primary peritoneal cancer View
None refractory ovarian cancer View
None refractory fallopian tube cancer View
None refractory peritoneal cancer View
None metastatic breast cancer View